Expression profiles of matrix metalloproteinases and their inhibitors in colonic inflammation related to pediatric inflammatory bowel disease

References

• Geboes K, De Hertogh G. Indeterminate colitis. Inflamm Bowel Dis 2003;9:324–31.
   PubMed Web of Science ®Google Scholar
• Oliva-Hemker M, Fiocchi C. Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective. Inflamm Bowel Dis 2002;8:112–28.
   PubMed Web of Science ®Google Scholar
• Kim SC, Ferry GD. Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology 2004;126:1550–60.
   PubMed Web of Science ®Google Scholar
• Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690–7.
   PubMed Web of Science ®Google Scholar
• Matsui T, Yao T, Sakurai T, Yao K, Hirai F, Matake H, Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation. J Gastroenterol 2003;38:647–55.
   PubMed Web of Science ®Google Scholar
• Carvalho RS, Abadom V, Dilworth HP, Thompson R, Oliva-Hemker M, Cuffari C. Indeterminate colitis: a significant subgroup of pediatric IBD. Inflamm Bowel Dis 2006;12:258–62.
   PubMed Web of Science ®Google Scholar
• Griffiths AM, Buller HB. Inflammatory bowel disease. In: Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, editors. Pediatric gastrointestinal diseases, 3rd ed. Hamilton, Ont.: Decker; 2000. p. 613–52.
   Google Scholar
• Turunen P, Ashorn M, Auvinen A, Iltanen S, Huhtala H, Kolho KL. Long-term health outcomes in pediatric inflammatory bowel disease: a population-based study. Inflamm Bowel Dis 2009;15:56–62.
   PubMed Web of Science ®Google Scholar
• Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994;18:165–73.
   PubMed Web of Science ®Google Scholar
• Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003;88:995–1000.
   PubMed Web of Science ®Google Scholar
• Ravi A, Garg P, Sitaraman SV. Matrix metalloproteinases in inflammatory bowel disease: boon or a bane? Inflamm Bowel Dis 2007;13:97–107.
   PubMed Web of Science ®Google Scholar
• Bailey CJ, Hembry RM, Alexander A, Irving MH, Grant ME, Shuttleworth CA. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol 1994;47:113–16.
   PubMed Web of Science ®Google Scholar
• Baugh MD, Perry MJ, Hollander AP, Davies DR, Cross SS, Lobo AJ, Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999;117:814–22.
   PubMed Web of Science ®Google Scholar
• Kirkegaard T, Hansen A, Bruun E, Brynskov J. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease. Gut 2004;53:701–9.
   PubMed Web of Science ®Google Scholar
• Heuschkel RB, MacDonald TT, Monteleone G, Bajaj-Elliott M, Smith JA, Pender SL. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut 2000;47:57–62.
   PubMed Web of Science ®Google Scholar
• Saarialho-Kere UK, Vaalamo M, Puolakkainen P, Airola K, Parks WC, Karjalainen-Lindsberg ML. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol 1996;148:519–26.
   PubMed Web of Science ®Google Scholar
• Stumpf M, Cao W, Klinge U, Klosterhalfen B, Junge K, Krones CJ, Reduced expression of collagen type I and increased expression of matrix metalloproteinases 1 in patients with Crohn's disease. J Invest Surg 2005;18:33–8.
   PubMed Web of Science ®Google Scholar
• Wang YD, Mao JW. Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis. World J Gastroenterol 2007;13:5926–32.
   PubMed Web of Science ®Google Scholar
• Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 1998;152:1005–14.
   PubMed Web of Science ®Google Scholar
• Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 2008;40:1334–47.
   PubMed Web of Science ®Google Scholar
• Matsuno K, Adachi Y, Yamamoto H, Goto A, Arimura Y, Endo T, The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis. J Gastroenterol 2003;38:348–54.
   PubMed Web of Science ®Google Scholar
• Rath T, Roderfeld M, Graf J, Wagner S, Vehr AK, Dietrich C, Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential? Inflamm Bowel Dis 2006;12:1025–35.
   PubMed Web of Science ®Google Scholar
• Bamba S, Lee C-Y, Brittan M, Preston SL, Direkze NC, Poulsom R, Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J Pathol 2006;209:265–73.
   PubMed Web of Science ®Google Scholar
• Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000;120:241–6.
   PubMed Web of Science ®Google Scholar
• Mäkitalo L, Sipponen T, Kärkkäinen P, Kolho K-L, Saarialho-Kere U. Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values. Int J Colorectal Dis 2009;24:1157–67.
   PubMed Web of Science ®Google Scholar
• Kuivanen T, Jeskanen L, Kyllönen L, Impola U, Saarialho-Kere UK. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13 are present in epithelial cells of keratoacanthomas. Mod Pathol 2006;19:1203–12.
   PubMedGoogle Scholar
• Isaka K, Nishi H, Nakai H, Nakada T, Feng Li Y, Ebihara Y, Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma. Cancer 2003;97:79–89.
   PubMed Web of Science ®Google Scholar
• Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562–73.
   PubMed Web of Science ®Google Scholar
• Bister V, Kolho KL, Karikoski R, Westerholm-Ormio M, Savilahti E, Saarialho-Kere U. Metalloelastase (MMP-12) is upregulated in the gut of pediatric patients with potential celiac disease and in type 1 diabetes. Scand J Gastroenterol 2005;40:1413–22.
   PubMed Web of Science ®Google Scholar
• Mohan MJ, Seaton T, Mitchell J, Howe A, Blackburn K, Burkhart W, The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. Biochemistry 2002;41:9462–9.
   PubMed Web of Science ®Google Scholar
• Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 2006;231:20–7.
   PubMed Web of Science ®Google Scholar
• Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 2000;105:143–50.
   PubMed Web of Science ®Google Scholar
• Madlener M, Mauch C, Conca W, Brauchle M, Parks WC, Werner S. Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing. Biochem J 1996;320:659–64.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Arimura Y, Goto A, Okahara S, Endo T, Shinomura Y, Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium. J Pathol 2006;209:376–83.
   PubMed Web of Science ®Google Scholar
• Freour T, Jarry A, Bach-Ngohou K, Dejoie T, Bou-Hanna C, Denis MG, TACE inhibition amplifies TNF-alpha-mediated colonic epithelial barrier disruption. Int J Mol Med 2009;23:41–8.
   PubMed Web of Science ®Google Scholar
• Cesaro A, Abakar-Mahamat A, Brest P, Lassalle S, Selva E, Filippi J, Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia. Am J Physiol Gastrointest Liver Physiol 2009;296:G1332–43.
   PubMedGoogle Scholar
• Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998;435:39–44.
   PubMed Web of Science ®Google Scholar
• Arihiro S, Ohtani H, Hiwatashi N, Torii A, Sorsa T, Nagura H. Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease. Histopathology 2001;39:50–9.
   PubMed Web of Science ®Google Scholar
• Pirila E, Ramamurthy NS, Sorsa T, Salo T, Hietanen J, Maisi P. Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 gamma2-chain expression in murine inflammatory bowel disease (ulcerative colitis). Dig Dis Sci 2003;48:93–8.
   PubMed Web of Science ®Google Scholar
• Ganguly K, Swarnakar S. Induction of matrix metalloproteinase-9 and -3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin. J Pineal Res 2009;47:43–55.
   PubMed Web of Science ®Google Scholar
• Bister VO, Salmela MT, Karjalainen-Lindsberg ML, Uria J, Lohi J, Puolakkainen P, Differential expression of three matrix metalloproteinases, MMP-19, MMP-26, and MMP-28, in normal and inflamed intestine and colon cancer. Dig Dis Sci 2004;49:653–61.
   PubMed Web of Science ®Google Scholar
• Pache I, Rogler G, Felley C. TNF-alpha blockers in inflammatory bowel diseases: practical consensus recommendations and a user's guide. Swiss Med Wkly 2009;139:278–87.
   PubMed Web of Science ®Google Scholar